Goodrx Holdings Inc
General ticker "GDRX" information:
- Sector: Health Care
- Industry: Health Care Technology
- Capitalization: $1.8B
Goodrx Holdings Inc does not follow the US Stock Market performance with the rate: -3.9%.
Estimated limits based on current volatility of 2.5%: low 4.34$, high 4.56$
Factors to consider:
- Company does not operate outside North America (retrieved using AI)
- Earnings for 18 months up through Q2 (+1 year) exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2022-12-31 to 2024-12-30
- 2022-12-31 to 2023-12-31 estimated range: [3.44$, 7.46$]
- 2023-12-31 to 2024-12-30 estimated range: [3.49$, 7.49$]
Financial Metrics affecting the GDRX estimates:
- Negative: Operating profit margin, % of 0.23 <= 1.03
- Positive: 0.10 < Non-GAAP EPS, $ of 0.30
- Negative: Industry operating cash flow per share per price (median), % of -7.54 <= 3.85
- Negative: negative Net income
- Positive: Interest expense per share, $ of 0.08 <= 0.14
Short-term GDRX quotes
Long-term GDRX plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $745.42MM | $766.55MM | $750.26MM |
| Operating Expenses | $732.02MM | $764.82MM | $777.27MM |
| Operating Income | $13.41MM | $1.74MM | $-27.01MM |
| Non-Operating Income | $-23.58MM | $-24.97MM | $-28.57MM |
| Interest Expense | $23.64MM | $34.24MM | $56.73MM |
| R&D Expense | $125.86MM | $143.14MM | $135.84MM |
| Income(Loss) | $-10.18MM | $-23.23MM | $-55.57MM |
| Taxes | $15.08MM | $9.60MM | $-46.70MM |
| Profit(Loss) | $-25.25MM | $-32.83MM | $-8.87MM |
| Stockholders Equity | $831.68MM | $814.83MM | $761.96MM |
| Inventory | $8.33MM | $0.00MM | $0.00MM |
| Assets | $1,607.62MM | $1,604.63MM | $1,588.80MM |
| Operating Cash Flow | $178.78MM | $146.78MM | $138.29MM |
| Capital expenditure | $34.46MM | $55.21MM | $55.77MM |
| Investing Cash Flow | $-178.73MM | $-210.50MM | $-55.77MM |
| Financing Cash Flow | $-30.53MM | $-120.23MM | $-167.40MM |
| Earnings Per Share* | $-0.06 | $-0.08 | $-0.02 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.